Investing
Emergent BioSolutions to lay off about 400 employees
© Reuters. FILE PHOTO: A nurse demonstrates the application of the NARCAN nasal spray medication at a outpatient treatment center in Indiana, Pennsylvania, U.S. August 9, 2017. Picture taken August 9, 2017. REUTERS/Adrees Latif/File Photo
(Reuters) – Emergent BioSolutions Inc said on Tuesday it plans to lay off about 400 employees across all businesses and cut back operations at some of its facilities.
The company added that it will reduce operations at its Bayview facility in Baltimore and the facility in Canton, Massachusetts.
Emergent will focus on its core products business of medical countermeasures and its overdose reversal nasal spray Narcan, the company said, adding that it will also do away with the chief operating officer role.
Read the full article here
-
Side Hustles4 days ago
Why the Best CEOs Think Like Anthropologists
-
Make Money5 days ago
Earn More in 2025: Top 10 High-Yield Savings Accounts Revealed
-
Side Hustles5 days ago
10 Roles That Are Surprisingly Well-Suited for Outsourcing
-
Side Hustles5 days ago
What to Do If TikTok is Banned — How to Protect Your Brand
-
Passive Income5 days ago
How Pets Can Promote Better Health and Well-Being in the Workplace
-
Side Hustles6 days ago
Meta Is Laying Off 5% of Its Workforce: Read the Memo
-
Make Money6 days ago
Build Your Future: 5 Simple Steps to Financial Stability
-
Investing2 days ago
TikTok faces US ban deadline as users brace for fallout By Reuters